Legend Biotech

Over the weekend, our #LEGENDary team joined the Multiple Myeloma Research Foundation - MMRF Walk / Run in NYC!     As the presenting sponsor for the third consecutive year, we were honored to have our CEO, Ying Huang, deliver the opening remarks to kick off the event.     Thank you to our #TeamForCures and everyone who walked, ran, volunteered, and cheered from the sidelines at #MMRFWalkRun! Your energy and dedication brought hope to those who need it most.     We are truly inspired to see the #MultipleMyeloma community come together to raise awareness and accelerate a path to a cure.

Our CEO, Ying Huang, recently sat down with Adil Ali, MD, at Onyx to discuss Legend’s journey advancing #CART #CellTherapies and how #Innovation is shaping the future of #HealthCare. Read the full interview produced by Onyx, published in Fortune: https://lnkd.in/e3Qp-S8e

We’re honored to be named a finalist for the Citeline #ScripAwards Biotech Company of the Year!    This recognition reflects the dedication of our entire team and our partners as we continue delivering transformative #CellTherapies to patients worldwide.     A heartfelt thank you to our #LEGENDary team, partners, and the patient community, who inspire our mission every day.  

As #BloodCancerAwareness Month comes to a close, we reflect on the progress made in science and treatment and draw inspiration from the strength of the #BloodCancer community.    At Legend, that inspiration fuels our commitment to advancing #CellTherapies with life-changing potential. We’re grateful for the opportunity to pursue this mission and remain dedicated to forging a path to a cure.     We look forward to a future where #BloodCancers and other difficult-to-treat diseases are curable.     #PatientsFirst #MakeBloodCancerVisible #KnowMyeloma 

Behind every patient with #BloodCancer is a network of caregivers, family, and friends providing support. At Legend, we celebrate these networks making a difference every day, helping patients navigate their journeys with strength and compassion. Their support plays a vital role in the fight against #BloodCancers. #BloodCancerAwareness #PatientsFirst #MakeBloodCancerVisible #KnowMyeloma

This week, we’re in Boston at the CAR-TCR Summit Series 2025! We’re proud to showcase our thought leadership and cutting-edge research. Check out what we have coming up: 🕐 Sept. 24 @ 8:20 a.m. ET Fireside Chat with Mythili Koneru 🕐 Sept. 24 @ 5:30 p.m. ET Plenary Session: Safety & Preliminary Efficacy of Claudin 18.2 & DLL3 Targeted CAR-T Cells in Gastric & Small Cell Lung Cancer with Mythili Koneru 🕐 Sept. 25 @ 1:45 p.m. ET Translating learnings outside of liquid tumors to advance cell therapy with Benjamin Oshrine We look forward to connecting with fellow innovators and sharing insights to drive the future of #CART #CellTherapies!

Our #LEGENDary global team is proud to wear red in recognition of #BloodCancerAwareness Month! By wearing red, we stand in solidarity with patients, caregivers, and families impacted by #BloodCancers, including #MultipleMyeloma, and reaffirm our mission to advance #CellTherapies that bring hope to those who need it most. It's inspiring to see everyone come together, and we’re proud to stand united in raising #BloodCancer awareness and #MakeBloodCancerVisible.

The Legend Biotech team is excited to attend the International Myeloma Society Annual Meeting in Toronto! Visit our booth #427 to meet our team and explore our portfolio of #CellTherapies. Discover how Legend is advancing innovative treatments, including our #CART #CellTherapy for #MultipleMyeloma, and learn about the positive impact we are making in the lives of patients. We’re thrilled to connect, collaborate, and exchange insights with the global myeloma community at #IMS2025. Together, we are driving progress! #IMS25 #Toronto2025

This past weekend, our #LEGENDary team laced up their sneakers to take part in the International Myeloma Foundation's 13th Annual #MiraclesforMyeloma 5K in Clark, New Jersey.   👏 A special shoutout to our colleagues Deepak Grover, Sr. SAP Capability Manager, and Nicholas Uy, Operations Associate, who each placed first in their respective age brackets!   It was an inspiring day of connection and purpose that brought together the #MultipleMyeloma community to raise awareness and vital funds for #Myeloma research.   We’re grateful for the opportunity to be the presenting sponsor for the second consecutive year, supporting this meaningful cause, and contributing to the mission of advancing treatments and striving toward a cure for Multiple Myeloma.

Blood Cancer Awareness Month is a reminder of the vital role research plays in improving patient outcomes. At Legend, pioneering our #CART #CellTherapies for #MultipleMyeloma demonstrates the team’s ongoing dedication to innovation, safety, and hope for patients with limited treatment options. We remain committed to forging a path to cure and pushing the boundaries of science for a world where #BloodCancers are no longer incurable. #BloodCancerAwareness #PatientsFirst #MakeBloodCancerVisible #KnowMyeloma